Molecular cytogenetic investigations of synchronous bilateral breast cancer

被引:22
作者
Agelopoulos, K
Tidow, N
Korsching, E
Voss, R
Hinrichs, B
Brandt, B
Boecker, W
Buerger, H
机构
[1] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany
[2] Univ Munster, Inst Clin Chem & Lab Med, D-48149 Munster, Germany
[3] Univ Munster, Atherosclerosis Res Inst, D-48149 Munster, Germany
[4] Univ Cologne, Inst Pathol, D-50996 Cologne, Germany
关键词
COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA IN-SITU; GENETIC PATHWAYS; HETEROZYGOSITY; INSTABILITY; DISEASE; REGION; TUMORS; BRCA1;
D O I
10.1136/jcp.56.9.660
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Bilaterality in breast cancer is a rare event and together with an early onset of disease points towards inheritance of the disease. However, most cases seem to occur sporadically, either in a synchronous or metachronous manner. Methods: Thirty two invasive carcinomas and one in situ carcinoma from 16 patients with synchronous, bilateral breast cancer were investigated by means of comparative genomic hybridisation (CGH) and polymerase chain reaction based multiplex microsatellite analysis. The results were analysed conventionally and were also subjected to a biomathematical cluster analysis. Results: On average, bilateral breast cancer cases showed a low number of genetic alterations, a low frequency of genetic amplifications, and a high rate of chromosomal 16q losses. A distinct, characteristic genetic alteration associated with bilateral breast disease could not be found. Although two tumour pairs appeared to be related using biomathematical processing for microsatellite analysis, this result was reproduced by CGH data processing in one patient only. Conclusions: Most synchronous, bilateral breast cancer cases seem to represent independent tumours rather than metastatic events. Nevertheless, the possibility of a specific susceptibility remains.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 27 条
[1]   Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast [J].
Buerger, H ;
Mommers, EC ;
Littmann, R ;
Diallo, R ;
Brinkschmidt, C ;
Poremba, C ;
Dockhorn-Dworniczak, B ;
van Diest, PJ ;
Böcker, W .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (06) :854-859
[2]  
Buerger H, 2000, CANCER RES, V60, P854
[3]  
Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO
[4]  
2-B
[5]  
Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO
[6]  
2-L
[7]  
Canzian F, 1996, CANCER RES, V56, P3331
[8]   BILATERAL BREAST-CANCER - ONE DISEASE OR 2 [J].
DAWSON, PJ ;
MALONEY, T ;
GIMOTTY, P ;
JUNEAU, P ;
OWNBY, H ;
WOLMAN, SR .
BREAST CANCER RESEARCH AND TREATMENT, 1991, 19 (03) :233-244
[9]  
Elston C.W., 1998, BREAST, V3rd
[10]   Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype [J].
Garcia, JM ;
Silva, JM ;
Dominguez, G ;
Gonzalez, R ;
Navarro, A ;
Carretero, L ;
Provencio, M ;
España, P ;
Bonilla, F .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (03) :237-243